• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性IgA肾病:牛津和班夫分类法揭示儿童和成人患者的不同特征并预测预后

IgA Nephropathy in Native Kidneys: Oxford and Banff Classifications Reveal Distinct Profiles and Predict Outcomes in Pediatric and Adult Patients.

作者信息

Milivojević Danijel, Nikolić Gorana, Tampe Björn, Pecić Maja, Babac Snežana, Paripović Dušan, Miloševski Lomić Gordana, Brković Voin, Baralić Marko, Janković Aleksandar, Đurić Petar, Stajić Nataša, Putnik Jovana, Radojević Škodrić Sanja, Životić Maja

机构信息

Institute of Pathology "Dr. Ðorđe Joannović", Faculty of Medicine, University of Belgrade, 11000 Belgrade, Serbia.

Department of Nephrology and Rheumatology, University Medical Center Göttingen, 37075 Göttingen, Germany.

出版信息

Life (Basel). 2025 Aug 3;15(8):1231. doi: 10.3390/life15081231.

DOI:10.3390/life15081231
PMID:40868879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12387574/
Abstract

IgA nephropathy is the most common primary glomerulonephritis, with pathohistological changes described by the Oxford classification, while the Banff classification is used in transplant pathology. This study included 253 patients with IgA nephropathy in native kidneys, divided into the pediatric ( = 105) and adult ( = 148) groups. It aimed to examine clinical, and Oxford and Banff morphological parameters in relation to age, correlations of clinical data with pathohistological parameters, and predictors of the disease outcome. Pediatric patients more frequently presented with macroscopic hematuria, while adults showed higher urea and creatinine levels, and lower eGFR. Examining Oxford classification parameters, chronic glomerular and tubulointerstitial lesions were more common in adults. Banff parameters revealed more frequent chronically active glomerular, inflammatory, chronic tubulointerstitial, and vascular lesions in adults. All inflammatory, chronic tubulointerstitial, and vascular parameters correlated with serum urea levels, eGFR and CKD stage in adults, while less frequent in pediatric patients. Tubulointerstitial Oxford and Banff parameters were strong predictors of CKD and proteinuria progression in children, while such predictors were fewer in adults; segmental glomerulosclerosis predicted hematuria progression in adults. Banff parameters (cg, t, ti, i, i-IFTA, ptc, cv), not in Oxford classification, significantly predict outcomes and are recommended for incorporation into IgA nephropathy reports.

摘要

IgA肾病是最常见的原发性肾小球肾炎,其病理组织学改变采用牛津分类法描述,而移植病理学中则使用班夫分类法。本研究纳入了253例原发性IgA肾病患者,分为儿童组(n = 105)和成人组(n = 148)。旨在研究临床、牛津和班夫形态学参数与年龄的关系、临床数据与病理组织学参数的相关性以及疾病预后的预测因素。儿童患者更常出现肉眼血尿,而成人患者的尿素和肌酐水平较高,估算肾小球滤过率(eGFR)较低。在检查牛津分类参数时,慢性肾小球和肾小管间质病变在成人中更为常见。班夫参数显示成人中慢性活动性肾小球、炎症、慢性肾小管间质和血管病变更为频繁。所有炎症、慢性肾小管间质和血管参数在成人中均与血清尿素水平、eGFR和慢性肾脏病(CKD)分期相关,而在儿童患者中相关性较低。肾小管间质牛津和班夫参数是儿童CKD和蛋白尿进展的强预测因素,而成人中的此类预测因素较少;节段性肾小球硬化预测成人血尿进展。班夫参数(cg、t、ti、i、i-IFTA、ptc、cv)不在牛津分类中,可显著预测预后,建议纳入IgA肾病报告中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/e2a7a03c815c/life-15-01231-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/02fd5260e053/life-15-01231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/284639c3304e/life-15-01231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/46f7c13732cd/life-15-01231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/5b1f78f6a175/life-15-01231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/3bed17cfd296/life-15-01231-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/cba9bb15a490/life-15-01231-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/1c604843eb29/life-15-01231-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/75e3bf8964df/life-15-01231-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/f4597e8cb52a/life-15-01231-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/6b0a6cd9eafe/life-15-01231-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/7dea0e8bc420/life-15-01231-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/55e8e235385a/life-15-01231-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/428ef6c1725c/life-15-01231-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/e2a7a03c815c/life-15-01231-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/02fd5260e053/life-15-01231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/284639c3304e/life-15-01231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/46f7c13732cd/life-15-01231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/5b1f78f6a175/life-15-01231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/3bed17cfd296/life-15-01231-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/cba9bb15a490/life-15-01231-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/1c604843eb29/life-15-01231-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/75e3bf8964df/life-15-01231-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/f4597e8cb52a/life-15-01231-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/6b0a6cd9eafe/life-15-01231-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/7dea0e8bc420/life-15-01231-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/55e8e235385a/life-15-01231-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/428ef6c1725c/life-15-01231-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b350/12387574/e2a7a03c815c/life-15-01231-g014.jpg

相似文献

1
IgA Nephropathy in Native Kidneys: Oxford and Banff Classifications Reveal Distinct Profiles and Predict Outcomes in Pediatric and Adult Patients.原发性IgA肾病:牛津和班夫分类法揭示儿童和成人患者的不同特征并预测预后
Life (Basel). 2025 Aug 3;15(8):1231. doi: 10.3390/life15081231.
2
Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.IgA 肾病牛津分类评估:系统评价和荟萃分析。
Am J Kidney Dis. 2013 Nov;62(5):891-9. doi: 10.1053/j.ajkd.2013.04.021. Epub 2013 Jun 29.
3
Transcriptomic Patterns in Adult and Pediatric Patients with IgA Nephropathy or IgA Vasculitis with Nephropathy.成人及儿童IgA肾病或IgA血管炎伴肾病的转录组学模式
J Am Soc Nephrol. 2025 Jul 1. doi: 10.1681/ASN.0000000787.
4
Defining the Etiology of Renal Allograft Dysfunction Using Banff 2019 Classification: Correlation with Post-Transplant Duration and Creatinine Levels-A Comprehensive Analysis of 200 Renal Biopsies at a Tertiary Care Medical Center Hospital.使用2019年班夫分类法定义肾移植功能障碍的病因:与移植后持续时间和肌酐水平的相关性——对一家三级医疗中心医院200例肾活检的综合分析
Int J Surg Pathol. 2024 Oct 3:10668969241283737. doi: 10.1177/10668969241283737.
5
Combined Effects of the Serum IgA/C3 Ratio and Glomerular C3 Staining on the Renal Outcome in Adult Immunoglobulin A Nephropathy.血清 IgA/C3 比值与肾小球 C3 染色对成人 IgA 肾病肾脏结局的联合影响。
Kidney Blood Press Res. 2024;49(1):246-257. doi: 10.1159/000536114. Epub 2024 Feb 21.
6
Is Childhood IgA Nephropathy Different From Adult IgA Nephropathy? A Narrative Review.儿童IgA肾病与成人IgA肾病不同吗?一篇叙述性综述。
Can J Kidney Health Dis. 2025 Mar 12;12:20543581251322571. doi: 10.1177/20543581251322571. eCollection 2025.
7
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
8
Immunosuppressive therapy for IgA nephropathy in children.儿童 IgA 肾病的免疫抑制治疗。
Cochrane Database Syst Rev. 2024 Jun 12;6(6):CD015060. doi: 10.1002/14651858.CD015060.pub2.
9
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在患有早期(1 至 3 期)非糖尿病慢性肾脏病的成人中的应用。
Cochrane Database Syst Rev. 2023 Jul 19;7(7):CD007751. doi: 10.1002/14651858.CD007751.pub3.
10
Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂治疗儿童 IgA 肾病的疗效和安全性。
Pediatr Nephrol. 2022 Mar;37(3):499-508. doi: 10.1007/s00467-021-05316-0. Epub 2021 Oct 22.

本文引用的文献

1
Significance of intrarenal vascular lesions in Ig A nephropathy prognosis.IgA 肾病预后中肾内血管病变的意义。
BMC Nephrol. 2024 Oct 16;25(1):355. doi: 10.1186/s12882-024-03803-8.
2
Prognosis of IgA nephropathy patient with proteinuria remission by supportive therapy: cohort from screening failed Chinese patients in TESTING study.支持治疗后蛋白尿缓解的 IgA 肾病患者的预后:TESTING 研究中筛查失败的中国患者队列。
Ren Fail. 2024 Dec;46(2):2398826. doi: 10.1080/0886022X.2024.2398826. Epub 2024 Sep 9.
3
Are children with IgA nephropathy different from adult patients?
儿童 IgA 肾病与成人患者有何不同?
Pediatr Nephrol. 2024 Aug;39(8):2403-2412. doi: 10.1007/s00467-024-06361-1. Epub 2024 Apr 5.
4
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and Future.IgA血管炎(过敏性紫癜)的回顾:过去、现在与未来
Med Sci Monit. 2024 Jan 28;30:e943912. doi: 10.12659/MSM.943912.
5
Long-Term Outcomes in IgA Nephropathy.IgA 肾病的长期预后。
Clin J Am Soc Nephrol. 2023 Jun 1;18(6):727-738. doi: 10.2215/CJN.0000000000000135. Epub 2023 Apr 13.
6
Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors.IgA 肾病队列的长期随访:结局和危险因素。
Ren Fail. 2023 Dec;45(1):2152694. doi: 10.1080/0886022X.2022.2152694.
7
IgA vasculitis update: Epidemiology, pathogenesis, and biomarkers.IgA 血管炎最新研究进展:流行病学、发病机制和生物标志物。
Front Immunol. 2022 Oct 3;13:921864. doi: 10.3389/fimmu.2022.921864. eCollection 2022.
8
Arteriolar hyalinosis and renal outcomes in patients with immunoglobulin A nephropathy.免疫球蛋白 A 肾病患者的小动脉玻璃样变性与肾脏结局。
Ren Fail. 2022 Dec;44(1):994-1003. doi: 10.1080/0886022X.2022.2083974.
9
Effect of Cyclophosphamide and Glucocorticoid Therapy in IgA Nephropathy: A Single-Center Retrospective Analysis.环磷酰胺和糖皮质激素治疗 IgA 肾病:单中心回顾性分析。
Kidney360. 2022 Jan 19;3(3):506-515. doi: 10.34067/KID.0006702021. eCollection 2022 Mar 31.
10
Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.肾间质炎症可预测IgA肾病的肾病进展:一项两中心队列研究
Am J Nephrol. 2022;53(6):455-469. doi: 10.1159/000524585. Epub 2022 May 16.